Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension

Name: Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension
Published: 2016
License: Public Domain

Histogen · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

cirrhosis livercirrhosis

cirrhosis, portal hypertension, non-alcoholic steatohepatitis, liver cirrhosis, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension

Related documents